Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine

Neuroscience

Volumn 132, Issue 4, 2005, Pages 991-1007

  Chan, C K S ^a   Burke, S L ^a   Zhu, H ^a,b   Piletz, J E ^a,c   Head, G A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c Jackson State University   (United States)

Author keywords

Blood pressure; Clonidine; Imidazoline receptors; Monoamine neurotoxins; Moxonidine; Rostroventrolateral medulla

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 5,6 DIHYDROXYTRYPTAMINE; ANTIHYPERTENSIVE AGENT; CLONIDINE; EFAROXAN; IMIDAZOLINE RECEPTOR; MOXONIDINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HYPOTENSION; MALE; MEDULLA OBLONGATA; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RABBIT; ROSTRAL VENTROLATERAL MEDULLA; SEROTONINERGIC SYSTEM; WESTERN BLOTTING;

EID: 18044386564     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.01.032     Document Type: Article

References (59)

1. 2A-adrenergic receptor-like immunoreactivity Brain Res 650 1994 181 204
2. B.I. Armah, E. Hofferber, W. Stenzel General pharmacology of the novel centrally acting antihypertensive agent moxonidine Arzneimittelforschung 38 1988 1426 1434
3. H.G. Baumgarten, K.D. Evetts, R.B. Holman, L.L. Iversen, M. Vogt, G. Wilson Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system J Neurochem 19 1972 1587 1597
4. F. Bennai, H. Greney, A. Molines, P. Bousquet, M. Dontenwill Antiidiotypic antibodies as tools to study imidazoline receptors Ann NY Acad Sci 763 1995 140 148
5. W.W. Blessing, A.K. Goodchild, R.A.L. Dampney, J.P. Chalmers Cell groups in the lower brain stem of the rabbit projecting to the spinal cord, with special reference to catecholamine-containing neurons Brain Res 221 1981 35 55
6. P. Bousquet, J. Feldman, R. Bloch, J. Schwartz The nucleus reticularis lateralis a region highly sensitive to clonidine Eur J Pharmacol 69 1981 389 392
7. P. Bousquet, J. Feldman, J. Schwartz Central cardiovascular effects of alpha adrenergic drugs differences between catecholamines and imidazolines J Pharmacol Exp Ther 230 1984 232 236
8. G.R. Breese, T.D. Traylor Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons J Pharmacol Exp Ther 174 1970 413 419
9. C.K.S. Chan, G.A. Head Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine J Hypertens 14 1996 855 864
10. C.K.S. Chan, F. Sannajust, G.A. Head Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits J Pharmacol Exp Ther 276 1996 411 420
11. M. Dontenwill, C. Vonthron, H. Greney, C. Magnier, F. Heemskerk, P. Bousquet Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors Ann NY Acad Sci 881 1999 123 134
12. J.L. Elghozi, G.A. Head, W.A. Wolf, C.R. Anderson, P.I. Korner Importance of spinal noradrenergic pathways in cardiovascular reflexes and central actions of clonidine and α-methyldopa in the rabbit Brain Res 499 1989 39 52
13. P. Ernsberger, J.E. Friedman, R.J. Koletsky The I1-imidazoline receptor from binding site to therapeutic target in cardiovascular disease J Hypertens 15 suppl 1997 S9 S23
14. P. Ernsberger, R. Guiliano, R.N. Willette, D.J. Reis Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla J Pharmacol Exp Ther 253 1990 408 418
15. P.R. Ernsberger, K.L. Westbrooks, M.O. Christen, S.G. Schafer A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors J Cardiovasc Pharmacol 20 suppl. 4 1992 S1 S10
16. P.V. Escriba, M. Sastre, H. Wang, S. Regunathan, D.J. Reis, J.A. Garcia-Sevilla Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues Neurosci Lett 178 1994 81 84
17. A. Flamez, J.-P. De Backer, E. Czerwiec, P. Ladure, G. Vauquelin Pharmacological characterization of I1 and I2 imidazoline receptors in human striatum Neurochem Int 30 1997 25 29
18. H. Greney, G. Bricca, M. Dontenwill, J. Stutzmann, P. Bousquet, A. Belcourt Characterization of imidazoline binding protein(s) solubilized from human brainstem studies with [h-3]idazoxan and [h-3]clonidine Neurochem Int 25 1994 183 191
19. 3H-rauwolscine to cortical membranes Naunyn Schmiedebergs Arch Pharmacol 328 1985 229 235
20. G.A. Head Central monoamine neurons and cardiovascular control Kidney Int 41 suppl. 37 1992 S8 S13
21. G.A. Head Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents Ann NY Acad Sci 763 1995 531 540
22. G.A. Head, S.L. Burke Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine J Cardiovasc Pharmacol 18 1991 819 826
23. G.A. Head, S.L. Burke Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetised rabbit J Hypertens 16 1998 503 517
24. G.A. Head, S.L. Burke, C.K. Chan Site and receptors involved in the sympathoinhibitory actions of rilmenidine J Hypertens 16 Suppl 1998 S7 S12
25. G.A. Head, P.R.C. Howe Effects of 6-hydroxydopamine and PNMT inhibitor LY134046 on pressor responses to stimulation of the subretrofacial nucleus in anaesthetized stroke-prone spontaneously hypertensive rats J Auton Nerv Syst 18 1987 213 224
26. G.A. Head, P.I. Korner Cardiovascular functions of brain serotonergic neurons in the rabbit as analysed from the acute and chronic effects of 5,6-dihydroxytryptamine J Cardiovasc Pharmacol 4 1982 398 408
27. G.A. Head, P.I. Korner, S.L. Lewis, E. Badoer Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and α-methyldopa in rabbits J Cardiovasc Pharmacol 5 1983 945 953
28. G.A. Head, F. Sannajust Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits Fundam Clin Pharmacol 6 suppl. 1 1992 31s 43s
29. F.M.J. Heemskerk, M. Dontenwill, H. Greney, C. Vonthron, P. Bousquet Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem J Neurochem 71 1998 2193 2202
30. P.R.C. Howe, E. Moon, R.A.L. Dampney Distribution of serotonin nerve cells in the rabbit brainstem Neurosci Lett 38 1983 125 130
31. D. Huangfu, W.B. Goodwin, P.G. Guyenet Sympatholytic effect of tricyclic antidepressants site and mechanism of action in anesthetized rats Am J Physiol 268 1995 R1429 R1441
32. A.L. Hudson, R.J. Tyacke, M.D. Lalies, N. Davies, D.P. Finn, O. Marti, E. Robinson, S. Husbands, M.C. Minchin, A. Kimura, D.J. Nutt Novel ligands for the investigation of imidazoline receptors and their binding proteins Ann NY Acad Sci 1009 2003 302 308
33. T.R. Ivanov, Y. Feng, H. Wang, S. Regunathan, D.J. Reis, D.N. Chikkala, P. Gupta, J.C. Jones, J.E. Piletz Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists J Psychiatr Res 32 1998 65 79
34. T.R. Ivanov, H. Zhu, S. Regunathan, D.J. Reis, M. Dontenwill, C. Vonthron, P. Bousquet, J.E. Piletz Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein Biochem Pharmacol 55 1998 649 655
35. B.R. Jacks, J. De Champlain, J.P. Cordeau Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system Eur J Pharmacol 18 1972 353 360
36. G. Jonsson, C. Sachs On the mode of action of 6-hydroxydopamine Chem Tools Catecholamine Res 1 1975 41 50
37. A. Kimura, R.J. Tyacke, M.C. Minchin, D.J. Nutt, A.L. Hudson Identification of an I(2) binding protein from rabbit brain Ann NY Acad Sci 1009 2003 364 366
38. P. Kotsonis, J. Binko, H. Majewski Noradrenaline synthesis after sympathetic nerve activation in rat atria and its dependence on calcium but not CAM kinase II and protein kinases A or C Br J Pharmacol 119 1996 1605 1613
39. H. Kurose, J.L. Arriza, R.J. Lefkowitz Characterization of alpha 2-adrenergic receptor subtype-specific antibodies Mol Pharmacol 43 1993 444 450
40. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage Nature 227 1970 680 685
41. 2A-adrenoceptors Eur J Pharmacol 167 1989 95 104
42. S.M. Lanier, B. Ivkovic, I. Singh, J.L. Neumeyer, V. Bakthavachalam Visualization of multiple imidazoline/guanidinium-receptive sites J Biol Chem 268 1993 16047 16051
43. 2A-adrenergic receptor subtype Science 273 1996 801 803
44. H.S. Maker, C. Weiss, T.S. Brannan Amine-mediated toxicity the effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the rat Neuropharmacology 25 1986 25 32
45. D.N. Mayorov, S.L. Burke, G.A. Head Relative importance of rostral ventrolateral medulla in sympathoinhibitory action of rilmenidine in conscious and anesthetized rabbits J Cardiovasc Pharmacol 37 2001 252 261
46. T.A. Milner, D.L. Rosin, A. Lee, S.A. Aicher Alpha(2A)-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla Brain Res 821 1999 200 211
47. F. Sannajust, G.A. Head Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors J Cardiovasc Pharmacol 23 1994 42 50
48. E. Schlicker, B.I. Armah, M. Gothert Central presynaptic α2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine J Cardiovasc Pharmacol 16 1990 15 22
49. B. Szabo, R. Urban Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine Arzneimittelforschung 47 1997 1009 1015
50. M. Tachikawa, M. Fukaya, T. Terasaki, S. Ohtsuki, M. Watanabe Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis Eur J Neurosci 20 2004 144 160
51. C.M. Tan, M.H. Wilson, L.B. MacMillan, B.K. Kobilka, L.E. Limbird Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists Proc Natl Acad Sci USA 99 2002 12471 12476
52. F. Tesson, I. Limonboulez, P. Urban, M. Puype, J. Vandekerckhove, I. Coupry, D. Pompon, A. Parini Localization of i-2-imidazoline binding sites on monoamine oxidases J Biol Chem 270 1995 9856 9861
53. F.P. Tolentino-Silva, M.A. Haxhiu, S. Waldbaum, I.A. Dreshaj, P. Ernsberger Alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice Brain Res 862 2000 26 35
54. M. Van den Buuse, G.A. Head, P.I. Korner Differential role of brain ascending noradrenergic bundles in the circulatory effects of a-methyldopa and clonidine J Cardiovasc Pharmacol 21 1993 112 119
55. C.F.H. Vonthron, H. Greney, P. Bousquet, M. Dontenwill Molecular characterization of human cerebral I1 imidazoline receptor Naunyn Schmiedebergs Arch Pharmacol 358 1998 R69
56. H. Wang, S. Regunathan, M.P. Meeley, D.J. Reis Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells Mol Pharmacol 42 1992 792 801
57. H. Wang, S. Regunathan, D.A. Ruggiero, D.J. Reis Production and characterization of antibodies specific for the imidazoline receptor protein Mol Pharmacol 43 1993 509 515
58. H. Zhu, A. Halaris, S. Madakasira, P. Pazzaglia, N. Goldman, C.L. DeVane, M. Andrew, D. Reis, J.E. Piletz Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients J Psychiatr Res 33 1999 323 333
59. H. Zhu, J. Hayes, M. Chen, J. Baldwin, J.E. Piletz Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS Ann NY Acad Sci 1009 2003 439 446